Dear gunsnkars,
Well, I went back and read the post#4999, but I'm not seeing your point(s).
Maybe I hurt your feelings by not recognizing that you already know Neupogen was approved for ARS? - BTW, you were replying to allo's post where she did not know there was an indication, not mine.
Or, were your upset because I criticized the fact that you started cheerleading for spidey's post #5064, which, in-fact, referenced the wrong studies, trying to claim there was NO survival benefit with N? Not good DD on your part, by the way.
And finally, your post below...I think you may be confused, as you mentioned in another post, you are not really an expert by anymeans on this.
Nevertheless, Please do share the name of the 'test' for radiation levels required to administer Neupogen in the event of ARS. I must have missed it in the actual pivitol trial and the approval documents. Here they are if you want to look them up and educate everyone.
When I do the math as you suggest, I come up with 1 million x dollars's. Is that what you came up with to? Certainly you did the DD on that before you posted, right? "Everyone has done their DD."
Definetlhy not smarter than everyone, just you.
Peace,
Auto1
gunsnkars Monday, 05/22/17 08:22:04 AM
Re: Auto1 post# 5113
Post #
5143
of 5163 Go
Hi Auto:
Go and read post #4999. The problem with you is you think you are the smartest one out here. Everyone has done their DD. No one blindly invests their hard earned money unless they believe in the company...I am long and don't expect quick bucks. I honestly believe PSTIs product is superior to Neupogen for ARS. The only advantage Neupogen has over PLX maybe the cost. However doesn't administering Neupogen require determining radiation levels through tests. Lets say the cost per test is X dollars . For 1 million people hope you can do the math.
